ApoE synthesis in human neuroblastoma cells

Neurobiology of Disease

Volumn 4, Issue 5, 1997, Pages 356-364

  Dupont Wallois, L ^a   Soulie C ^a   Sergeant, N ^a   Wavrant De Wrieze, N ^a   Chartier Harlin, M C ^a   Delacourte, A ^a   Caillet Boudin, M L ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPOPROTEIN SYNTHESIS; NEUROBLASTOMA CELL; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0031461093     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1997.0155     Document Type: Article

References (55)

1. Ammer, H., & Schulz, R. (1994) Retinoic acid-induced differentiation of human neuroblastoma SH-SY 5Y cells is associated with changes in the abundance of G proteins. J. Neurochem. 62, 1310-1318.
2. Arai, Y., Mizuguchi, M., Ikeda, K., & Takashima, S. (1996) Transient expression of apolipoprotein-E in neonates with pontosubicular neuron necrosis. Acta Neuropathol. 91, 396-399.
3. Benzing, W. C., & Mufson, E. J. (1995) Apolipoprotein E immunoreactivity within neurofibrillary tangles: Relationship to Tau and PHF in Alzheimer's disease. Exp. Neural 132, 162-171.
4. Biedler, J. L., Helson, L., & Splenger, B. A. (1973) Morphology and growth, tumorigenecity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652.
5. Biedler, J. L., Rofler-Tarlow, S., Schachner, M., & Freedman, L. S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3757.
6. Buée, L., Pérez-Tur, J., Leveugle, B., Buée-Scherrer, V., Mufson, E. J., Loerzel, A. J., Chartier-Harlin, M. C., Perl, D. P., Delacourte, A., & Hof, P. R. (1996) Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: Genotype analysis and relationship to neuropathologic changes. Acta Neuropathol. 91, 254-262.
7. Carden, M. J., Trojanowski, J. Q., Schlaepfer, W. W., & Lee, V. M. (1987) Two stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns. J. Neurosci. 7, 3489-3504.
8. Chartier-Harlin, M. C., Parfitt, M., Legrain, S., Pérez-Tur, J., Brousseau, T., Evans, A., Berr, C., Vidal, O., Roques, P., Gourlet, V., Fruchart, J. C., Delacourte, A., Rossor, M., & Amouyel, P. (1994) Apolipoprotein E, ∈4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3, 569-574.
9. Cochard, P., & Paulin, D. (1984) Initial expression of neurofilament and vimentin in the central and peripheral nervous system of the mouse embryo in vivo. J. Neurosci. 4, 2080-2094.
10. Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Jr., Rimmler, J. B., Locke, P. A., Conneally, P. M., Scmader, K. E., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7, 180-184.
11. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., & Gaskell, P. C. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
12. David, J. P., Fallet-Bianco, C., Vermersch, P., Frigard, B., Dimenza, C., & Delacourte, A. (1994) Normal cerebral aging: Study of the glial reaction. C. R. Acad. Sci. Paris 317, 749-753.
13. Diedrich, J. F., Minnigan, H., Carp, R. I., Whitaker, J. N., Race, R., Frey, W., & Haase, A. T. (1991) Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin in astrocytes. J. Virol. 65, 4759-4768.
14. Dupont-Wallois, L., Sautière, P. E., Cocquerelle, C., Bailleul, B., Delacourte, A., & Caillet-Boudin, M. L. (1995) Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid. FEBS Lett. 357, 197-201.
15. Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA 82, 203-207.
16. Fleming, J., Weisgraber, K. H., Strittmatter, W. J., Troncoso, J. C., & Johnson, G. V. W. (1996) Differential binding of apolipoprotein E isoforms to Tau and other cytoskeletal proteins. Exp. Neurol. 138, 252-260.
17. Frisoni, G. B., Govoni, S., Geroldi, C., Bianchetti, A., Calabresi, L., Franceschini, G., & Trabucchi, M. (1995) Gene dose of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann. Neurol. 37, 596-604.
18. Gracia, V., Fiol, C., Hurtado, I., Pinto, X., Argimon, J. M., & Castineiras, M. J. (1994) An enzyme-linked immunosorbent assay method to measure human apolipoprotein E levels using commercially available reagents: Effect of apolipoprotein E polymorphism on serum apolipoprotein E concentration. Anal. Biochem. 223, 212-217.
19. Han, S. H., Einstein, G., Weisgraber, K., Strittmatter, W. J., Saunders, A. M., Pericak-Vance, M., Roses, A., & Schmechel, D. E. (1994a) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53, 535-544.
20. Han, S. H., Hulette, C., Saunders, A. M., Einstein, G., Pericak-Vance, M., Strittmatter, W. J., Roses, A. D., & Schmechel, D. E. (1994b) Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol. 128, 13-26.
21. Huang, D. Y, Weisgraber, K. H., Goedert, M., Saunders, A., Roses, A. D., & Strittmatter, W. J. (1995) ApoE3 binding to Tau repeat I is abolished by Tau serine262 phosphorylation. Neurosci. Lett. 192, 209-212.
22. Jensen, T. G., Roses, A. D., & Jorgensen, A. L. (1994) Apolipoprotein E uptake and degradation via chloroquine-sensitive pathway in cultivated monkey cells overexpressing low density lipoprotein receptor. Neurosci. Lett. 180, 193-196.
23. Krieger, M., & Herz, J. (1994) Structures and functions of multiligand lipoproteins receptors: Macrophage scavenger receptors and LDL-receptor-related protein (LRP). Annu. Rev. Biochem. 63, 601-637.
24. Ledesma, M. D., Moreno, F. J., Pérez, M. M., & Avila, J. (1996) Binding of apoliprotein E3 to tau protein: Effects on tau glycation, tau phosphorylation, and tau-microtubule binding in vitro. Alzheimer's Res. 2, 85-88.
25. Lefranc, D., Vermersch, P., Dallongeville, J., Daems-Montpeurt, C., Petit, H., & Delacourte, A. (1996) Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. Neurosci. Lett. 212, 91-94.
26. Leroy, A., Vu-Dac, N., Koffigan, M., Clavey, V., & Fruchart, J. C. (1988) Characterization of a monoclonal-antibody that binds to apolipoprotein E and to lipoprotein of human plasma containing apoE: Applications to ELISA quantification of plasma apoE. J. Immunol 9, 309-334.
27. Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M. X., Maestre, G., Ngai, C., Tycho, B., & Ginsberg, H. (1993) The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann. Neurol 34, 752-754.
28. Metzger, R. E., LaDu, M. J., Pan, J. B., Getz, G. S., Frail, D. E., & Fadulto, M. T. (1996) Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 372-380.
29. Muller, H. W., Gebick-Herter, P. J., Hangen, D. H., & Shooter, E. M. (1985) A specific-37,000 Dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. Science 228, 499-501.
30. Namba, Y., Tomonawa, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jacob disease. Brain Res. 541, 163-166.
31. Pérez-Tur, J., Campion, D., Martinez, M., Brice, A., Tardieu, S., Hannequin, D., Agid, Y., Delacourte, A., Clerget-Dapoux, F., & Chartier-Harlin, M. C. (1995) Evidence for apolipoprotein E4 association in early onset Alzheimer's patients with late-onset relatives. Am. J. Med. Genet. 60, 550-553.
32. Poirier, J., Davignon, J., Bohtillier, D., Kogan, S., Bertrand, P., & Gauthier, S. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699.
33. Poirier, J., Hess, M., May, P. C., & Finch, C. E. (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11, 97-106.
34. Reeves, S. A., Helman, L. J., Allison, A., & Israel, M. A. (1989) Molecular cloning and primary structure of human glial fibrillary acidic protein. Proc. Natl. Acad. Sci. USA 86, 5178-5182.
35. Richey, P. L., Siedlak, S. L., Smith, M. A., & Perry, G. (1995) Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: Implications for disease pathogenesis. Biochem. Biophys. Res. Commun. 208, 657-663.
36. Sanchez, J. C., Appel, R. D., Golaz, O., Pasquali, C., Ravier, F., Bairoch, A., & Hochtrasser, D. F. (1995) Inside SWISS-2DPAGE database. Electrophoresis 16, 1131-1151.
37. Saunders, A. M., Strittmatter, W. J., Schmechel, D., St George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D., & Roses, A. D. (1993) Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
38. Sautière, P. E., Caillet-Boudin, M. L., Wattez, A., & Delacourte, A. (1994) Detection of Alzheimer-type Tau proteins in okadaic acid-treated SKNSH-SY 5Y neuroblastoma cells. Neurodegeneration 3, 53-60.
39. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
40. Schmechel, D., Tiller, O., Tong, P., McSwain, M., Han, S. H., Ange, R., Burkhart, D., & Izard, M. (1996) Pattern of apolipoprotein E immunoreactivity during brain aging. In: Apolipoprotein E and Alzheimer's disease (A. Roses, K. Weigraber, & Y. Christen, Eds.), pp. 27-48. Fondation Ipsen/Springer-Verlag, Berlin.
41. Schwab, M., Alitalo, K., Klempnauer, K. H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., & Trent, J. (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305, 245-248.
42. Seeger, R. C., Rayner, S. A., Banerjee, A., Chung, H., Laug, W. E., Neustein, H. B., & Benedict, W. F. (1977) Morphology, growth, chromosomal pattern, and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res. 37, 1364-1371.
43. Sergeant, N., David, J. P., Jakes, R., Vermersch, P., Buée, L., Lefranc, D., Wattez, A. & Delacourte, A. (1997) Two-dimensional characterization of PHF-Tau from Alzheimer's disease: Demonstration of an additional 74 kDa component and age-related biochemical modifications. J. Neurochem., 69, 836-866.
44. Singh, I. N., Sorrentino, G., McCartney, D. G., Massarelli, R., & Kanfer, J. N. (1990) Enzymatic activities during differentiation of the human neuroblastoma cells, LA-N-1 and LA-N-2. J. Neurosci. 25, 476-485.
45. Sternberger, L. A., & Sternberger, N. H. (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA 80, 6126-6130.
46. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., & Enghild, J. (1993) Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
47. Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y, Pericak-Vance, M., Schmechel, D., & Roses, A. D. (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 11183-11186.
48. Visviskis, S., Steinmetz, J., Cuvelier, I., Galteau, M. M., & Siest, G. (1986) Study of ApoE Polymorphism Using Two-Dimensional Electrophoresis. In: Electrophorèse Bidimensionelle, pp. 159-166. Presses Univ. France, Nancy.
49. Weisgraber, K. H., Rall, S. C., Jr., & Mahley, R. W. (1981) Human E apolipoprotein heterogeneity. J. Biol. Chem. 256, 9077-9083.
50. + ionophore. Cancer Res. 37, 1372-1376.
51. Wisniewski, T., Castano, E. M., Golabek, A., Vogel, T., & Frangione, B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol 145, 1030-1035.
52. Xu, P. T., Schmechel, D., Rothrock-Christian, T., Buckart, D. S., Qiu, H. L., Popko, B., Sullivan, P., Maeda, N., Saunders, A. M., Roses, A. D., & Gilbert, J. R. (1996) Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: Human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3, 229-245.
53. Zanni, E. E., Kouvasi, A., Hadzopoulou-Cladaras, M., Krieger, M., & Zannis, V. I. (1989) Expression of apoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. J. Biol. Chem. 264, 9137-9140.
54. Zannis, V. I., & Breslow, J. L. (1981) Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry 20, 1033-1041.
55. Zannis, V. I., McPherson, J., Goldgerger, G., Karathanasis, S. K., & Breslow, J. L. (1986) Synthesis, intracellular processing and signal peptide of human apolipoprotein E. J. Biol. Chem. 259, 5495-5499.